<p>Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator</p>-Reference-Cited by-同舟云学术

Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Published:2020-03 Issue: Volume:Volume 12 Page:1543-1567
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Chen Li,Kong Xiangyi,Wang Zhongzhao,Wang Xiangyu,Fang Yi,Wang Jing

Publisher

Informa UK Limited

Subject

Oncology

Reference41 articles.

1. Cancer statistics in China, 2015

2. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level

3. Time to initiation of neo‐adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients

4. Concurrent Neoadjuvant Chemotherapy and Radiation Therapy in Locally Advanced Breast Cancer

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the link: Neonicotinoids and elevated cardiometabolic risks in Chinese rural residents–from a prospective cohort study combing mendelian randomization study;Journal of Hazardous Materials;2024-09

2. Preoperative Blood Counts Predict Overall Survival in Patients Undergoing Surgical Removal of Brain Metastasis;World Neurosurgery;2024-06

3. Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis;Anticancer Research;2024-04-27

4. Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator;Journal of Neuro-Oncology;2024-04-25

5. Prognostic Value of CRP–Albumin–Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer;International Journal of General Medicine;2024-03